Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

ClinicalTrials.gov ID: NCT00150384

Public ClinicalTrials.gov record NCT00150384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 11:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Utility Of Caduet In Simultaneously Achieving Blood Pressure And Lipid Endpoints In A Specific Patient Population (CAPABLE)

Study identification

NCT ID
NCT00150384
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

  • Amlodipine/Atorvastatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Not listed
Completion
Jul 31, 2005
Last update posted
Jan 26, 2021

2004 – 2005

United States locations

U.S. sites
106
U.S. states
26
U.S. cities
76
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35209
Pfizer Investigational Site Birmingham Alabama 35211
Pfizer Investigational Site Huntsville Alabama 35801
Pfizer Investigational Site Little Rock Arkansas 72204
Pfizer Investigational Site Los Angeles California 90024
Pfizer Investigational Site Oakland California 94609-3425
Pfizer Investigational Site Pico Rivera California 90660
Pfizer Investigational Site Bridgeport Connecticut 6610
Pfizer Investigational Site Washington D.C. District of Columbia 20010
Pfizer Investigational Site Washington D.C. District of Columbia 20037
Pfizer Investigational Site Aventura Florida 33180
Pfizer Investigational Site Gainesville Florida 32601
Pfizer Investigational Site Jacksonville Florida 32204
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Pensacola Florida 32503
Pfizer Investigational Site Vero Beach Florida 32960
Pfizer Investigational Site Athens Georgia 30606
Pfizer Investigational Site Atlanta Georgia 30303
Pfizer Investigational Site Atlanta Georgia 30309
Pfizer Investigational Site Atlanta Georgia 30310
Pfizer Investigational Site Atlanta Georgia 30342
Pfizer Investigational Site Augusta Georgia 30904
Pfizer Investigational Site Columbus Georgia 31901
Pfizer Investigational Site Columbus Georgia 31904
Pfizer Investigational Site Decatur Georgia 30033
Pfizer Investigational Site Lincolnton Georgia 30817
Pfizer Investigational Site Savannah Georgia 31406
Pfizer Investigational Site Chicago Illinois 60616
Pfizer Investigational Site Chicago Illinois 60637-1470
Pfizer Investigational Site Maywood Illinois 60153
Pfizer Investigational Site Merrillville Indiana 46410
Pfizer Investigational Site Overland Park Kansas 66211
Pfizer Investigational Site Bossier City Louisiana 71111
Pfizer Investigational Site New Orleans Louisiana 70117-4817
Pfizer Investigational Site New Orleans Louisiana 70125
Pfizer Investigational Site Shreveport Louisiana 71101
Pfizer Investigational Site Shreveport Louisiana 71130
Pfizer Investigational Site Baltimore Maryland 21201
Pfizer Investigational Site Baltimore Maryland 21215
Pfizer Investigational Site Columbia Maryland 21045
Pfizer Investigational Site Randallstown Maryland 21133
Pfizer Investigational Site Rockville Maryland 20850
Pfizer Investigational Site Westminster Maryland 21157
Pfizer Investigational Site Brockton Massachusetts 02301
Pfizer Investigational Site Wellesley Hills Massachusetts 02481-2106
Pfizer Investigational Site Detroit Michigan 48201
Pfizer Investigational Site Detroit Michigan 48235
Pfizer Investigational Site Lansing Michigan 48917
Pfizer Investigational Site Livonia Michigan 48152
Pfizer Investigational Site Jackson Mississippi 39202
Pfizer Investigational Site Jackson Mississippi 39216
Pfizer Investigational Site Kansas City Missouri 64112
Pfizer Investigational Site Kansas City Missouri 64131
Pfizer Investigational Site St Louis Missouri 63104
Pfizer Investigational Site St Louis Missouri 63110
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Cherry Hill New Jersey 08034
Pfizer Investigational Site East Orange New Jersey 07018
Pfizer Investigational Site Elizabeth New Jersey 07202
Pfizer Investigational Site Hammonton New Jersey 08037
Pfizer Investigational Site South Bound Brook New Jersey 08880
Pfizer Investigational Site Voorhees Township New Jersey 08043
Pfizer Investigational Site Woodbury New Jersey 08096
Pfizer Investigational Site Brooklyn New York 11203
Pfizer Investigational Site Brooklyn New York
Pfizer Investigational Site Buffalo New York 14215
Pfizer Investigational Site Mineola New York 11501
Pfizer Investigational Site Charlotte North Carolina 28209
Pfizer Investigational Site Greenville North Carolina 27834
Pfizer Investigational Site Monroe North Carolina 28112
Pfizer Investigational Site Monroe North Carolina
Pfizer Investigational Site Winston-Salem North Carolina 27103-3315
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Cincinnati Ohio 45229
Pfizer Investigational Site Cincinnati Ohio 45236
Pfizer Investigational Site Cincinnati Ohio 45246
Pfizer Investigational Site Dayton Ohio 45402
Pfizer Investigational Site Dayton Ohio 45406
Pfizer Investigational Site Maumee Ohio 43537
Pfizer Investigational Site Perrysburg Ohio 43551
Pfizer Investigational Site Bensalem Pennsylvania 19020
Pfizer Investigational Site Philadelphia Pennsylvania 19141
Pfizer Investigational Site Philadelphia Pennsylvania 19146
Pfizer Investigational Site Philadelphia Pennsylvania 19148
Pfizer Investigational Site Bamberg South Carolina 29003
Pfizer Investigational Site Charleston South Carolina 29425
Pfizer Investigational Site Clinton South Carolina 29325
Pfizer Investigational Site Mt. Pleasant South Carolina 29464
Pfizer Investigational Site Simpsonville South Carolina 29681
Pfizer Investigational Site Bartlett Tennessee 38134
Pfizer Investigational Site Jackson Tennessee 38305
Pfizer Investigational Site Beaumont Texas 77702
Pfizer Investigational Site Dallas Texas 75235
Pfizer Investigational Site Dallas Texas 75254
Pfizer Investigational Site Houston Texas 77024
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Houston Texas 77054
Pfizer Investigational Site Emporia Virginia 23847
Pfizer Investigational Site Norfolk Virginia 23502
Pfizer Investigational Site Norfolk Virginia 23510
Pfizer Investigational Site Richmond Virginia 23249
Pfizer Investigational Site Richmond Virginia 23294
Pfizer Investigational Site Virginia Beach Virginia 23454
Pfizer Investigational Site Virginia Beach Virginia 23455
Pfizer Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00150384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2021 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00150384 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →